Nathaniel Liddy

1.5k total citations
11 papers, 391 citations indexed

About

Nathaniel Liddy is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nathaniel Liddy has authored 11 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nathaniel Liddy's work include CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Nathaniel Liddy is often cited by papers focused on CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Nathaniel Liddy collaborates with scholars based in United Kingdom, United States and Australia. Nathaniel Liddy's co-authors include Bent K. Jakobsen, Annelise Vuidepot, Peter Molloy, Kyong‐Mi Chang, Milos Aleksic, Nick Pumphrey, Andrew K. Sewell, Alan Bennett, Florian Madura and Anna Fuller and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Nathaniel Liddy

11 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathaniel Liddy United Kingdom	8	315	248	95	69	52	11	391
Timothy T. Spear United States	10	240 0.8×	194 0.8×	107 1.1×	66 1.0×	60 1.2×	18	354
Praveen D. Chatani United States	5	241 0.8×	194 0.8×	214 2.3×	37 0.5×	33 0.6×	11	382
John Zielinski United States	4	236 0.7×	134 0.5×	177 1.9×	37 0.5×	64 1.2×	5	360
Belén Palencia Spain	9	205 0.7×	161 0.6×	92 1.0×	17 0.2×	43 0.8×	14	296
Don G. Lee South Korea	11	251 0.8×	191 0.8×	69 0.7×	22 0.3×	25 0.5×	13	355
Alok V. Joglekar United States	7	244 0.8×	156 0.6×	156 1.6×	73 1.1×	31 0.6×	8	344
Ho S. Oh South Korea	11	277 0.9×	206 0.8×	64 0.7×	22 0.3×	23 0.4×	13	377
Iva Zlatareva United Kingdom	7	402 1.3×	152 0.6×	63 0.7×	34 0.5×	15 0.3×	8	483
Daniel Brändle Switzerland	7	442 1.4×	154 0.6×	96 1.0×	50 0.7×	36 0.7×	7	492
Jim Middelburg Netherlands	8	143 0.5×	179 0.7×	70 0.7×	77 1.1×	30 0.6×	13	308

Countries citing papers authored by Nathaniel Liddy

Since Specialization

Citations

This map shows the geographic impact of Nathaniel Liddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Liddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Liddy more than expected).

Fields of papers citing papers by Nathaniel Liddy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel Liddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Liddy. The network helps show where Nathaniel Liddy may publish in the future.

Co-authorship network of co-authors of Nathaniel Liddy

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel Liddy. A scholar is included among the top collaborators of Nathaniel Liddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel Liddy. Nathaniel Liddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Collins, Laura C., Ricardo J. Carreira, Adel Benlahrech, et al.. (2024). High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer–testis antigen PRAME. PubMed. 4(1). ltae008–ltae008. 2 indexed citations

Madura, Florian, P.J. Rizkallah, Mateusz Legut, et al.. (2019). TCR‐induced alteration of primary MHC peptide anchor residue. European Journal of Immunology. 49(7). 1052–1066. 17 indexed citations

Bossi, Giovanna, Jane Harper, Joseph Dukes, et al.. (2015). ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations

Hassan, Namir J., Giovanna Bossi, Katherine J. Adams, et al.. (2014). Abstract 2900: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma. Cancer Research. 74(19_Supplement). 2900–2900. 1 indexed citations

Madura, Florian, P.J. Rizkallah, Kim Miles, et al.. (2013). T-cell Receptor Specificity Maintained by Altered Thermodynamics. Journal of Biological Chemistry. 288(26). 18766–18775. 32 indexed citations

Cole, David K., Kim Miles, Florian Madura, et al.. (2013). T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions. Journal of Biological Chemistry. 289(2). 628–638. 52 indexed citations

Aleksic, Milos, Nathaniel Liddy, Peter Molloy, et al.. (2012). Different affinity windows for virus and cancer‐specific T‐cell receptors: Implications for therapeutic strategies. European Journal of Immunology. 42(12). 3174–3179. 183 indexed citations

Plesa, Gabriela, Lingjie Zheng, Andrew Medvec, et al.. (2012). TCR affinity and specificity requirements for human regulatory T-cell function. Blood. 119(15). 3420–3430. 48 indexed citations

Liddy, Nathaniel, Peter Molloy, Alan Bennett, et al.. (2010). Production of a Soluble Disulfide Bond-Linked TCR in the Cytoplasm of Escherichia coli trxB gor Mutants. Molecular Biotechnology. 45(2). 140–149. 9 indexed citations

10.

Purbhoo, Marco A., Yi Li, Deborah H. Sutton, et al.. (2007). The HLA A*0201–restricted hTERT540–548 peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Molecular Cancer Therapeutics. 6(7). 2081–2091. 36 indexed citations

11.

Taylor, G.L., Andrew Sullivan, Nathaniel Liddy, et al.. (2001). X-Ray Crystal Structure of a Monoclonal Antibody That Binds to a Major Autoantigenic Epitope on Thyroid Peroxidase. Thyroid. 11(12). 1091–1099. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact